Iconic Brands, Inc. ICNB
Take ICNB for instance. We put this forth yesterday as a momentum play, and after touching a low of .022, the stock surged ahead, closing at .055. Total possible single-session gains: 150%
Amarin Corp. Plc AMRN
Despite receiving FDA approval for their new drug, AMRN appears to be gapping down this morning. After all of the hype and baked-in PPS leading into the approval date, it appears the stock now wants consolidate. Excessive profit-taking in these instances can hold back the progress of a stock, so we will be observing for any possible bounces.
BEDMINSTER, N.J. and DUBLIN, Ireland, July 26, 2012 (GLOBE NEWSWIRE) — Amarin Corporation plc (Nasdaq:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today that the U.S. Food and Drug Administration (FDA) has approved Vascepa(TM) (icosapent ethyl) capsules (formerly known as AMR101) as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe (TG greater than or equal to 500mg/dL) hypertriglyceridemia (very high triglycerides).
AK Steel Holding Corp. AKS & Arch Coal, Inc. ACI
On June 18th, we alerted ACI as a bottom-fishers dream, and the stock subsequently ran from a low of 5.41 to 7.63 for a gain of 41% The stock saw a new low yesterday (5.16), and again seems like a good one to watch for a possible upcoming bounce.
AKS is exhibiting some similar characteristics to ACI. The charts are alike in many ways, and like ACI, AKS is hovering around a bottom. Therefore, we want to keep an eye on it moving forward, in the event that it matches the kind of bounce we saw in ACI.
IMDS, AAPT, RENU, BBDA, STEM, NOK